Richie Soong is a Senior Principal Investigator in the Cancer Science Institute of Singapore (CSI Singapore) and a Research Associate Professor in the Department of Pathology at the National University of Singapore. He heads the “Translational Interface” (TI) core facility in CSI Singapore, which is a unique facility dedicated to translational research. He is also Scientific Director of the NUS Diagnostic Molecular Oncology Centre. Born and bred in Australia, A/Prof. Soong completed a PhD on the clinical relevance of alterations to the p53 tumour suppressor in the Departments of Surgery and Obstetrics and Gynaecology at The University of Western Australia. Richie Soong is a Senior Principal Investigator in the Cancer Science Institute of Singapore (CSI Singapore) and a Research Associate Professor in the Department of Pathology at the National University of Singapore. He heads the “Translational Interface” (TI) core facility in CSI Singapore, which is a unique facility dedicated to translational research. He is also Scientific Director of the NUS Diagnostic Molecular Oncology Centre. Born and bred in Australia, A/Prof. Soong completed a PhD on the clinical relevance of alterations to the p53 tumour suppressor in the Departments of Surgery and Obstetrics and Gynaecology at The University of Western Australia.

Pharmacogenomics, Biomarker discovery and validation, Customization of chemotherapy to races, Circulating tumor cell analysis, microRNA, DNA methylation.